Your shopping cart is currently empty

di-DTPA-LTL is a divalent hapten designed based on tyrosine-containing polypeptides. It exhibits excellent hydrophilicity and biodistribution properties. di-DTPA-LTL is labeled with 111In (indium) and 131I (iodine). By administering a fixed low dose (5 mg) of a bispecific antibody (anti-CEA x, anti-DTPA) and the di-DTPA hapten peptide (labeled with 111In) to patients, di-DTPA-LTL enables tumor radioimmunoimaging in patients with primary colorectal cancer expressing CEA.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | di-DTPA-LTL is a divalent hapten designed based on tyrosine-containing polypeptides. It exhibits excellent hydrophilicity and biodistribution properties. di-DTPA-LTL is labeled with 111In (indium) and 131I (iodine). By administering a fixed low dose (5 mg) of a bispecific antibody (anti-CEA x, anti-DTPA) and the di-DTPA hapten peptide (labeled with 111In) to patients, di-DTPA-LTL enables tumor radioimmunoimaging in patients with primary colorectal cancer expressing CEA. |
| Formula | C52H82N12O23 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.